1 Table of Contents_x000D_
1.1 List of Tables_x000D_
1.2 List of Figures_x000D_
2 Introduction_x000D_
2.1 What Is This Report About?_x000D_
2.2 Ophthalmic Devices Market Segmentation_x000D_
2.3 Definitions of Markets Covered in the Report_x000D_
3 Ophthalmic Devices Market, United States_x000D_
3.1 Ophthalmic Devices Market, United States, Revenue ($m), 2018-2033_x000D_
3.2 Ophthalmic Devices Market, United States, Revenue Mix ($m), 2023_x000D_
3.3 Ophthalmic Devices Market, United States, Category Contribution by Revenue ($m), 2023_x000D_
3.4 Ophthalmic Devices Market, United States, Revenue ($m), 2018-2033_x000D_
3.5 Ophthalmic Devices Market, United States, Volume (Units), 2018-2033_x000D_
3.6 Ophthalmic Devices Market, United States, Volume (Units), 2018-2033_x000D_
3.7 Ophthalmic Devices Market, United States, Company Share by Revenue ($m), 2023_x000D_
4 Corneal Implants Market, United States_x000D_
4.1 Corneal Implants Market, United States, Revenue Mix ($m), 2023_x000D_
4.2 Corneal Implants Market, United States, Segment Contribution (%), 2023_x000D_
4.1 Corneal Implants Market, United States, Revenue ($m), 2018-2033_x000D_
4.2 Corneal Implants Market, United States, Volume (Units), 2018-2033_x000D_
4.3 Corneal Implants Market, United States, Average Price ($), 2018-2033_x000D_
4.4 Corneal Implants Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
4.5 Corneal Implants Market, United States, Company Share by Revenue ($m), 2023_x000D_
5 Glaucoma Surgery Devices Market, United States_x000D_
5.1 Glaucoma Surgery Devices Market, United States, Revenue Mix ($m), 2023_x000D_
5.2 Glaucoma Surgery Devices Market, United States, Segment Contribution (%), 2023_x000D_
5.3 Glaucoma Surgery Devices Market, United States, Revenue ($m), 2018-2033_x000D_
5.3.1 Glaucoma Drainage Devices Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
5.4 Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033_x000D_
5.4.1 Glaucoma Drainage Devices Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
5.5 Glaucoma Surgery Devices Market, United States, Average Price ($), 2018-2033_x000D_
5.6 Glaucoma Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
5.7 Glaucoma Surgery Devices Market, United States, Company Share by Revenue ($m), 2023_x000D_
6 Intraocular Lens (IOL) Market, United States_x000D_
6.1 Intraocular Lens (IOL) Market, United States, Revenue Mix ($m), 2023_x000D_
6.2 Intraocular Lens (IOL) Market, United States, Segment Contribution (%), 2023_x000D_
6.3 Intraocular Lens (IOL) Market, United States, Revenue ($m), 2018-2033_x000D_
6.3.1 Foldable IOL Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
6.4 Intraocular Lens (IOL) Market, United States, Volume (Units), 2018-2033_x000D_
6.4.1 Foldable IOL Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
6.5 Intraocular Lens (IOL) Market, United States, Average Price ($) , 2018-2033_x000D_
6.6 Intraocular Lens (IOL) Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
6.7 Intraocular Lens (IOL) Market, United States, Company Share by Revenue ($m), 2023_x000D_
7 Ophthalmic Lasers Market, United States_x000D_
7.1 Ophthalmic Lasers Market, United States, Revenue Mix ($m), 2023_x000D_
7.2 Ophthalmic Lasers Market, United States, Segment Contribution (%), 2023_x000D_
7.3 Ophthalmic Lasers Market, United States, Revenue ($m), 2018-2033_x000D_
7.4 Ophthalmic Lasers Market, United States, Volume (Units), 2018-2033_x000D_
7.5 Ophthalmic Lasers Market, United States, Average Price ($), 2018-2033_x000D_
7.6 Ophthalmic Lasers Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
7.7 Ophthalmic Lasers Market, United States, Company Share by Revenue ($m), 2023_x000D_
8 Ophthalmic Viscoelastic Devices (OVD) Market, United States_x000D_
8.1 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue Mix ($m), 2023_x000D_
8.2 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Segment Contribution (%), 2023_x000D_
8.3 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue ($m), 2018-2033_x000D_
8.4 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Volume (Units), 2018-2033_x000D_
8.5 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Average Price ($) , 2018-2033_x000D_
8.6 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
8.7 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Company Share by Revenue ($m), 2023_x000D_
9 Overview of Key Companies in United States, Ophthalmic Devices Market_x000D_
9.1 Alcon Inc_x000D_
9.1.1 Company Overview_x000D_
9.2 Johnson & Johnson Vision Care Inc_x000D_
9.2.1 Company Overview_x000D_
9.3 Bausch & Lomb Inc_x000D_
9.3.1 Company Overview_x000D_
9.4 Glaukos Corp_x000D_
9.4.1 Company Overview_x000D_
9.5 SightLife_x000D_
9.5.1 Company Overview_x000D_
9.6 Allergan Aesthetics_x000D_
9.6.1 Company Overview_x000D_
9.7 Carl Zeiss Meditec AG_x000D_
9.7.1 Company Overview_x000D_
9.8 Meridian Ag_x000D_
9.8.1 Company Overview_x000D_
9.9 CorneaGen Inc_x000D_
9.9.1 Company Overview_x000D_
9.10 New World Medical, Incorporated_x000D_
9.10.1 Company Overview_x000D_
10 Ophthalmic Devices Market Pipeline Products_x000D_
11 Financial Deals Landscape_x000D_
11.1 Acquisition_x000D_
11.1.1 Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories_x000D_
11.1.2 Sonendo to Acquire Biolase for USD14 Million_x000D_
11.1.3 Sanner Acquires Gilero_x000D_
11.1.4 CYIOS Acquires Noir Medical Supplies_x000D_
11.1.5 Advancing Eyecare Holdings Acquires Eyefficient_x000D_
11.1.6 Bausch + Lomb Acquires Trukera Medical from Accelmed Partners_x000D_
11.1.7 DuPont de Nemours Acquires Donatelle Plastics_x000D_
11.1.8 Sightpath Medical Acquires PennVista_x000D_
11.1.9 Nordson Acquires Atrion For USD800 Million_x000D_
11.1.10 Specac Acquires Harrick Scientific_x000D_
11.1.11 Chadwick Optical Acquires Aire-O-Lite Optical_x000D_
11.2 Debt Offerings_x000D_
11.2.1 Iridex to Raise USD4.2 Million in Private Placement of Senior Convertible Promissory Notes_x000D_
11.2.2 Vitazi.AI Raises USD0.66 Million in Debt Offering_x000D_
11.2.3 OPKO Health to Raise USD250 Million in Public Offering of
7.5% Notes Due 2044_x000D_
11.2.4 Clearflow (Clear Cathetar Systems) Raises USD2.32 Million in Debt Offering_x000D_
11.2.5 Becton, Dickinson and Co Raises USD600 Million in Public Offering of
5.081% Notes due 2029_x000D_
11.2.6 Becton Dickinson Raises USD1.09 Billion in Public Offering of
3.828% Notes due 2032_x000D_
11.2.7 JelliSee Ophthalmics Raises Additional USD2.05 Million in Debt Financing_x000D_
11.2.8 Becton, Dickinson and Company (Becton Dickinson and Co) Raises USD625 Million in Public Offering of
4.874% Notes Due 2029_x000D_
12 Recent Developments_x000D_
12.1 Corporate Communications_x000D_
12.1.1 Dec 03, 2024: Exergen Unveils Improved Award-Winning TemporalScanner TAT-2000C for At-home Use in US and Canada_x000D_
12.1.2 Dec 03, 2024: Canon Medical Informatics Selected by Major Non-profit Health System to Standardize Advanced Visualization across 25+ Locations_x000D_
12.1.3 Sep 23, 2024: OPKO Health’s ModeX Therapeutics Names Giovanni Abbadessa as Chief Medical Officer_x000D_
12.1.4 Sep 10, 2024: Marshall B. Ketchum University Names Greta Vines-Douglas as Director of School of Physician Assistant Studies_x000D_
12.1.5 Sep 09, 2024: Stryker Spine Receives Additional FDA 510(k) Clearance for Vitoss BiModal Bioactive Bone Graft Substitute Foam Strip_x000D_
12.1.6 Sep 09, 2024: Boston Scientific Receives Additional 510(K) Clearance For Epic Biliary Endoscopic Stent System_x000D_
12.1.7 Sep 03, 2024: Samsara Vision Promotes Jason Herod to Chief Commercial Officer_x000D_
12.1.8 Jul 18, 2024: Eyenuk Appoints Bryan Haardt as Chief Executive Officer_x000D_
12.1.9 Jul 01, 2024: AMETEK Names Keith Kowalski as Vice President and General Manager, AMS Division_x000D_
12.1.10 Jun 14, 2024: Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its
2.75% Convertible Senior Notes Due 2027 for Common Stock_x000D_
12.1.11 Jun 05, 2024: VSP Vision Hires Usha Patil as Chief Insurance Officer_x000D_
12.1.12 May 31, 2024: Children’s Hospital of Philadelphia Appoints New Chief of Gastroenterology, Hepatology and Nutrition_x000D_
12.1.13 May 09, 2024: AMETEK Appoints Patrick L. Williams Vice President and General Manager, Maintenance, Repair, Overhaul (MRO) Division_x000D_
12.1.14 May 07, 2024: Oculis Publishes Invitation to the Annual General Meeting_x000D_
12.1.15 May 06, 2024: Andon Health Receives 510(K) Clearance For Fully Automatic Electronic Blood Pressure Monitor (KD-5811VA)_x000D_
12.1.16 Mar 28, 2024: Mojo Vision Hires Achin Bhowmik to Board of Directors_x000D_
12.1.17 Mar 25, 2024: Stony Brook Professor George Leibowitz Assumes Role from Interim Dean Richard L. Edwards_x000D_
12.2 Financial Announcements_x000D_
12.2.1 Jan 07, 2025: Biodesix Announces Publication of a New Nodify CDT Clinical Validation Study_x000D_
12.2.2 Dec 05, 2024: CooperCompanies Releases Q4 and Full Year 2024 Financial Results_x000D_
12.2.3 Dec 04, 2024: Foshan SOCO Precision Instrument Receives 510(K) Clearance ForHigh-Speed Air Turbine Handpiece Model – SCHF22_x000D_
12.2.4 Dec 04, 2024: Hangzhou Clongene Biotech Receives CLIA Approval For CLUNGENE Fentanyl Home Test Cassette_x000D_
12.2.5 Dec 03, 2024: ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine_x000D_
12.2.6 Dec 03, 2024: Reveal Genomics and IEO initiate breast cancer test impact study_x000D_
12.2.7 Dec 02, 2024: Sernova Update on Strategic Initiatives_x000D_
12.2.8 Dec 02, 2024: Ascelia Pharma Presents Orviglance Sparkle Study Primary Results as Cutting-Edge Research at the 2024 RSNA Annual Meeting_x000D_
12.2.9 Oct 31, 2024: Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024_x000D_
12.2.10 Oct 30, 2024: STAAR Surgical Announces Q3 2024 Results_x000D_
12.2.11 Oct 23, 2024: STAAR Surgical to Report Third Quarter Results on October 30, 2024_x000D_
12.2.12 Oct 17, 2024: Anika Announces Third Quarter 2024 Results Conference Call Date_x000D_
12.2.13 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results_x000D_
12.2.14 Oct 09, 2024: Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4_x000D_
12.2.15 Oct 03, 2024: Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024_x000D_
12.2.16 Sep 26, 2024: Regeneron to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on October 31, 2024_x000D_
12.2.17 Aug 27, 2024: Oculis Announces Results for Quarter Ended June 30, 2024_x000D_
12.2.18 Aug 13, 2024: Syntec Optics to Host Conference Call to Discuss Financial Results and Business Update_x000D_
12.2.19 Aug 08, 2024: Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th_x000D_
12.2.20 Aug 02, 2024: Interface Announces Q2 2024 Results_x000D_
12.2.21 Aug 01, 2024: NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024_x000D_
12.2.22 Aug 01, 2024: LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024_x000D_
12.2.23 Aug 01, 2024: Regeneron Reports Second Quarter 2024 Financial and Operating Results_x000D_
12.2.24 Jul 30, 2024: Corning Reports Strong Second-Quarter 2024 Financial Results, Exceeding April Guidance and Marking Return to Year-over-Year Sales Growth_x000D_
12.2.25 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024_x000D_
12.2.26 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings_x000D_
12.2.27 Jun 24, 2024: Zhejiang Zahndent Biotechnology Receives 510(K) Clearance For ZD-ST-C Dental Zirconia Block_x000D_
12.2.28 Jun 24, 2024: Zhejiang Zahndent Biotechnology Receives 510(K) Clearance For ZD-3D-Pro ML Dental Zirconia Block_x000D_
12.2.29 Jun 21, 2024: NX Development Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan_x000D_
12.2.30 Jun 17, 2024: OMNIVISION Announces Smallest Camera Module for 3D Intraoral Dental Scanners_x000D_
12.2.31 May 14, 2024: Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th_x000D_
12.2.32 May 09, 2024: Warby Parker Announces First Quarter 2024 Results_x000D_
12.2.33 May 06, 2024: Microline Surgical Receives An Additional 510(k) Clearance For ReNew XR Handpiece_x000D_
12.2.34 May 06, 2024: Huizhou Foryou Medical Devices Receives An Additional 510(k) Clearance For LUOFUCON Collagen Wound Dressing_x000D_
12.2.35 May 06, 2024: UG GLOBAL RESOURCES SDN BHD Receives 510(K) Clearance For_x000D_
Black Pearl Nitrile Examination Glove_x000D_
12.2.36 May 06, 2024: Andon Health Receives 510(K) Clearance For Fully Automatic Electronic Blood Pressure Monitor (KD-5810VA)_x000D_
12.2.37 May 06, 2024: Regeneron Announces Investor Conference Presentations_x000D_
12.2.38 May 02, 2024: Mammoth Biosciences to Present at Annual Meeting of the American Society of Gene & Cell Therapy_x000D_
12.2.39 Apr 26, 2024: Gentex Reports First Quarter 2024 Financial Results_x000D_
12.2.40 Apr 15, 2024: Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1_x000D_
12.2.41 Apr 04, 2024: BD to Announce Financial Results for its Second Quarter of Fiscal 2024_x000D_
12.2.42 Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024_x000D_
12.2.43 Feb 27, 2024: Interface Announces Q4 and Full Year 2023 Results_x000D_
12.2.44 Jan 30, 2024: Corning Reports Fourth-Quarter and Full-Year 2023 Financial Results_x000D_
12.2.45 Jan 26, 2024: Gentex Reports Fourth Quarter and Year End 2023 Financial Results_x000D_
12.2.46 Jan 16, 2024: Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1_x000D_
12.3 Government and Public Interest_x000D_
12.3.1 Nov 14, 2024: Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue Eye Care Recycling Programs_x000D_
12.3.2 Apr 29, 2024: BD to Present at Bank of America Securities Health Care Conference 2024_x000D_
12.3.3 Mar 11, 2024: Solco Biomedical Receives Additional 510(K) Clearance For 4CIS VERTU Spine System_x000D_
12.3.4 Mar 06, 2024: STAAR Surgical to Participate in Two Upcoming Investor Conferences_x000D_
12.3.5 Feb 15, 2024: BD to Present at Investor Healthcare Conferences_x000D_
12.3.6 Feb 05, 2024: FibroGen to Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024_x000D_
12.3.7 Jan 22, 2024: Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024_x000D_
12.4 Legal And Regulatory_x000D_
12.4.1 Dec 18, 2024: Moberg Pharma Announces New terbinafine Supplier Secured_x000D_
12.4.2 Sep 09, 2024: Insulet Receives Additional FDA 510(k) Clearance for Omnipod 5 POD Delivery System_x000D_
12.4.3 Sep 09, 2024: Boston Scientific Receives Additional 510(K) Clearance For Rhythmia HDx Mapping System_x000D_
12.4.4 Sep 06, 2024: Fujifilm Healthcare Europe Announces ARIETTA 750 FF ENDO Compatibility with Fujifilm Ultrasound Endoscopes and Endobronchial Ultrasound Scope_x000D_
12.4.5 Jul 01, 2024: CDRH Announces Expansion of the Total Product Life Cycle Advisory Program_x000D_
12.5 Other Significant Developments_x000D_
12.5.1 Oct 29, 2024: Solutionreach Introduces Secure Documents Tool to Aid Optometry Practices with FTC Eyeglass Rule Compliance_x000D_
12.5.2 Oct 11, 2024: Non-invasive eye test for multiple diseases to advance under $4.8M NIH award_x000D_
12.5.3 Oct 08, 2024: VisionVentions Launches to Revolutionize Ophthalmic Device Innovation with Advanced Additive Manufacturing_x000D_
12.5.4 Sep 12, 2024: MellingMedical Signs NX Contracts to Source Topcon Devices_x000D_
12.5.5 Sep 11, 2024: ID Mystyle 3 and ID Workstyle 3 to Share Hoya’s Best Technology Platform Lead by Adaptease Technology_x000D_
12.5.6 Aug 28, 2024: JEDMED Joins MellingMedical's Lineup of Medical Products Providers_x000D_
12.5.7 Jul 30, 2024: Corning Reports Strong Second-Quarter 2024 Financial Results, Exceeding April Guidance and Marking Return to Year-over-Year Sales Growth_x000D_
12.5.8 May 02, 2024: Ocutrx Technologies Sets New Standards in Augmented and Mixed Reality with Over 25 Groundbreaking Patents for Transformative Healthcare and More_x000D_
12.5.9 Apr 12, 2024: Syntec Optics Secures Order to Develop New Disposable Optics for Digital Health Treatment_x000D_
12.5.10 Apr 04, 2024: STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024_x000D_
12.5.11 Feb 21, 2024: AmoyDx PD-L1 (E1L3N) assay gained the priority recommendation from Chinese expert consensus_x000D_
12.5.12 Feb 05, 2024: Corning’s New Advanced Flow Pharmaceutical Technology Services Will Help Speed the Creation of Future Medicines_x000D_
12.6 Product News_x000D_
12.6.1 Nov 20, 2024: Mann Eye Institute First in Texas to Offer Revolutionary Glaucoma Treatment With Voyager DSLT_x000D_
12.6.2 Nov 07, 2024: Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh_x000D_
12.6.3 Oct 16, 2024: Elysium Health Announces the Launch of Vision for Eye Longevity, Performance, and Protection_x000D_
12.6.4 Oct 15, 2024: Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance_x000D_
12.6.5 Oct 07, 2024: NTC Launches Imperial, the New Eye Drops Product Line on the Patient’s Side_x000D_
12.6.6 Oct 01, 2024: ASU Researchers Use AI to Help People See More Clearly_x000D_
12.6.7 Sep 12, 2024: OCuSOFT and Dr. Paul Karpecki Set the Record Straight on Retaine MGD_x000D_
12.6.8 Aug 27, 2024: Bruder Healthcare Introduces Eyeleve MGD, A Trusted Eye Drop Formula Under A New Brand_x000D_
12.6.9 Aug 17, 2024: Pulse Biosciences Receives Additional FDA 510(k) Clearance for CellFX Percutaneous Electrode System_x000D_
12.6.10 Aug 13, 2024: New UH Study Targets Early Signs of Vision Loss in Diabetic Patients_x000D_
12.6.11 Aug 01, 2024: New Zeiss Study Finds Majority of Parents Worry about Impact of Screen Time on Their Children’s Eye Health, Value Protective Behaviors to Maintain Eyesight_x000D_
12.6.12 Jul 29, 2024: UW Model Shows Cortical Implants Like Elon Musk’s Blindsight Unlikely to ‘Exceed Normal Human Vision’_x000D_
12.6.13 Jul 23, 2024: Mann Eye Institute Introduces Cutting-Edge miCOR Technology for Advanced Cataract Surgery_x000D_
12.6.14 Jul 15, 2024: Eye Injection Kit Recall: Bausch + Lomb/Synergetics Removes Certain I-Pack Injection Kits Due to Potential Non-Sterility_x000D_
12.6.15 Jul 08, 2024: Emory University Announces AI Technology Advances Early Detection of Severe Eye Inflammation, New Research Shows_x000D_
12.6.16 Jun 10, 2024: Bausch + Lomb INFUSE for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States_x000D_
12.6.17 Jun 03, 2024: BioTissue Introduces CAM360 AmnioGraft, Redefining Regenerative Therapy for Dry Eye and Other Ocular Surface Disorders_x000D_
12.6.18 May 28, 2024: Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting_x000D_
12.6.19 Apr 30, 2024: Heidelberg Engineering Showcases the Future of Imaging, Extending Its Capabilities with a Breadth of Research Technology_x000D_
12.6.20 Apr 29, 2024: Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting_x000D_
12.6.21 Apr 25, 2024: Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi and Clobetasol Propionate Ophthalmic Suspension_x000D_
12.6.22 Apr 15, 2024: ForSight Robotics Completes Robotic Cataract Surgery Using ORYOM Platform_x000D_
12.6.23 Apr 12, 2024: Syntec Optics Secures Order to Develop New Disposable Optics for Digital Health Treatment_x000D_
12.6.24 Apr 10, 2024: AI Makes Retinal Imaging 100 Times Faster, Compared to Manual Method_x000D_
12.6.25 Apr 09, 2024: Verana Health to Reveal Results from Largest Pediatric Intraocular Lens Study, Funded by the FDA, During AAPOS 2024_x000D_
12.6.26 Apr 04, 2024: WCG Launches Total Feasibility for Faster, More Efficient Study Planning & Site Selection_x000D_
12.6.27 Apr 04, 2024: Verana Health Developing Qdata Dry Eye Disease, the Largest Real-World Dataset of its Kind_x000D_
12.6.28 Apr 03, 2024: Eyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetings_x000D_
12.6.29 Feb 22, 2024: RetinalGeniX Technologies Granted a Patent for System And Method For Visualization Of Ocular Anatomy_x000D_
12.6.30 Feb 05, 2024: Electronic Adhesives by Meridian EPO-TEK Highlighted at MD&M West_x000D_
12.7 Strategy And Business Planning_x000D_
12.7.1 Dec 03, 2024: Aavantgarde Announces Oral Presentation of Luce-1 Clinical Study at Floretina 2024 Annual Meeting_x000D_
12.7.2 Nov 07, 2024: Harrow Announces Nationwide Launch of New Digital Patient Access Solution in Collaboration With Asembia_x000D_
12.7.3 May 30, 2024: Corning Launches New Digital and IT Center in Pune, India_x000D_
12.7.4 Apr 25, 2024: Polyu Forms Global Partnership with Zeiss Vision Care to Expand Impact and Accelerate Market Penetration of Patented Myopia Control Technology_x000D_
12.7.5 Apr 24, 2024: Athenahealth and the American Council of the Blind Collaborate to Expand Digital Accessibility for Athenahealth Patients_x000D_
12.7.6 Mar 22, 2024: Guangzhou Xinbo Electronic Received Additional FDA 510(K) Clearance For Pain Therapy Device_x000D_
13 Appendix_x000D_
13.1 Research Methodology_x000D_
13.1.1 Coverage_x000D_
13.1.2 Secondary Research_x000D_
13.1.3 Primary Research_x000D_
13.1.4 Market Modeling and Forecasting_x000D_
13.1.5 Company Share Analysis_x000D_
13.1.6 Distribution Share Analysis_x000D_
13.1.7 Benchmarking_x000D_
13.2 GlobalData Consulting_x000D_
13.3 Contact Us_x000D_
13.4 Disclaimer
